The two complementary strands of siRNAs (1 M) were incubated in 0.15 M NaCl, 0.05 M NaH 2 PO 4 , pH 7.2 buffer. The samples were protected from light or irradiated at 365 nm with a UV transilluminator for 20 min, heated to 100 C for 2 min, and then cooled to 20 C at a rate of 2 C/min, held at 20 C for 5 min, then heated to 100 C at a rate of 2 C/min. Absorbance was recorded at 260 nm every 1 C. The T m was determined by the maximum of the first derivative of the absorbance vs. temperature plot. Standard deviations were calculated form three individual experiments. A. GFP B. CGFP-1 C. CGFP-2 D. CGFP-3 E. CGFP-4 F. Eg5 G. CEg5-1 H. CEg5-2 I. CEg5-3 J. CEg5-4 K. CEg5-5
Synthetic Protocols (E)-N'-(9-((4aR,6R,7R,7aR)-2,2-di-tert-butyl-7-((tert-butyldimethylsilyl)oxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-1-((1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethoxy)methyl)-6-oxo-6,9-dihydro-1H-
purin-2-yl)-N,N-dimethylformimidamide (4). The guanosine derivative 2 was synthesized as previously reported.(44) The NPOM caging group 3 was prepared according to the previously described synthesis.(45) The silyl protected guanosine 2 (100 mg, 0.17 mmol) was dissolved in DMF (1 mL) with DBU (38 L, 0.25 mmol). NPOM-Cl 3 (64 mg, 0.25 mmol) dissolved in DMF (0.5 mL) was added dropwise, and the solution was stirred for 12 h at room temperature. EtOAc (10 mL) was added and the organic layer was washed with saturated aqueous NaHCO 3, water, and brine (10 mL each). The organic layer was dried over anhydrous Na 2 SO 4 , filtered, and the solvent was evaporated. Purification of the crude product by silica gel chromatography using a hexanes/EtOAc gradient (70:30 to 50:50) containing 2% TEA afforded 4 as a yellow foam in 79% yield (108 mg, 0.13 mmol). (1 mL). The reaction mixture was stirred at room temperature for 2 h and then diluted with EtOAc (10 mL).
The resulting mixture was washed with saturated aqueous NaHCO 3 , water, and brine (10 mL each). The organic layer was dried over anhydrous Na 2 SO 4 and concentrated to give an oily residue. Purification of the residue by sílica gel chromatography using hexanes/EtOAc (30:70) with 2% TEA afforded 7 as a yellow foam in 56% yield (62 mg, 0.056 mmol). 4aR,6R,7R,7aR)-2-(tert-butyl)-2-butyl-7-((tert-butyldimethylsilyl)oxy)tetrahydro-4H-furo[3,2-d][1,3,2] dioxasilin-6-yl)pyrimidine-2,4(1H,3H)-dione (9). Uridine 8 (2.0 g, 8.2 mmol) was coevaporated with dry pyridine (2 x 10 mL), then dissolved in dry DMF (20 mL), and cooled to 0 ºC. (tBu) 2 (OTf) 2 Si (2.85 mL, 8.8 mmol), was added via a syringe pump over 45 min and the reaction mixture was stirred for another 45 min at 0 ºC. Imidazole (2.72 g, 40 mmol) was added, and the reaction was brought to room temperature, followed by the slow addition of tert-butyldimethylchlorosilane (1.578 g, 10.4 mmol). The reaction mixture was then heated to 60 ºC for 4 h, cooled to room temperature, and the solvent was removed by rotatory evaporation. Water (60 mL) and chloroform (120 mL) were added, the layers were separated and the organic layer was washed with brine (2 x 30 mL) and dried with anhydrous Na 2 SO 4 , gravity filtered, and evaporated by rotatory evaporation. The oily residue was purified by column chromatography using CHCl 3 /MeOH (100:1), delivering the product 9 as a white solid (3.9 g, 97%). 4aR,6R,7R,7aR)-2-(tert-butyl)-2-butyl-7-((tert-butyldimethylsilyl)oxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxasilin-6-yl)-3-((1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethoxy)methyl)pyrimidine-2,4(1H,3H) dione (10). The silyl-protected uridine 9 (1.0g, 2.62 mmol) was dissolved in dry DMF (15 mL) and cooled to 0 ºC, and Cs 2 CO 3 (2.0 g, 6.06 mmol) was added. NPOM chloride 3 (0.62 g, 2.38 mmol) was dissolved in DMF (1.5 mL), cooled to 0 ºC and the solution was slowly added into the protected uridine over 10 minutes and the reaction mixture was then allowed to warm to room temperature. After 16 hours, the solvent was removed by rotary evaporation and the residue was dissolved in EtOAc (100 mL) and water (50 mL), the organic layer was separated, washed with brine (3 x 15 mL), dried over anhydrous Na 2 SO 4 , filtered and evaporated. The oily residue was purified by column chromatography on silica gel using hexanes/EtOAc (6:1 to 3:1), delivering the product 10 as an off-white solid (1.12 g, 77%). 744.2960; found 744.2952.
1-((

1-((2R,3R,4R,5R)-3-((tert-butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-
3-((1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethoxy)methyl)pyrimidine-2,4(1H,3H)-dione (11).
The silyl protected caged uridine 10 (157 mg, 0.22 mmol) was dissolved in DCM (0.9 mL) and cooled to 0 ºC. A chilled solution of hydrogen fluoride-pyridine (23.6 µL, 70% HF-pyridine, 0.91 mmol) in 145 µL pyridine was added and the reaction was stirred at 0 ºC for 1 h. The solution was washed with water (10 mL) and with a saturated aqueous NaHCO 3 (10 mL). The organic layer was dried with Na 2 SO 4 , filtered and concentrated via rotatory evaporation. The residue was purified by column chromatography on silica gel using CHCl 3 /MeOH (100:1 to 25:1), furnishing the product 11 as an off-white solid (98 mg, 77%). DIPEA (0.14 g, 1.08 mmol) was added and the reaction mixture was stirred at 0 ºC for 10 min NCCH 2 CH 2 OP[N(i-C 3 H 7 ) 2 ]Cl (0.13 g, 0.54 mmol, 2 eq.) was added and the resulting reaction mixture was gradually allowed to warm to room temperature over 12 h. MeOH (0.5 mL) was added and the reaction was concentrated by rotatory evaporation. The residue was purified by column chromatography on silica gel using hexanes/CHCl 3 /Et 3 N (100:20:1), delivering the product 12 as a foamy yellow solid (0.26 g, 91%). 
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